by Ben Bartee
The Daily Bell
Ongoing litigation by OxyContin victims and their families against Purdue Pharma, the dangerous and addictive pusher of the drug, has critical lessons to impart on the true incentives of pharmaceutical giants – and more, importantly, their impacts on average people.
The history of pharmaceutical profiteering over human health offers lessons that we cannot morally ignore in the context of life-altering “puberty blockers” for “transgender” children:
“Puberty can be confusing or difficult for a child who is transgender, genderqueer, nonbinary or questioning their gender…. Puberty blockers, also called hormone blockers, help delay unwanted physical changes that don’t match someone’s gender identity.”